RxSight, Inc. (RXST)
12.59
+0.11
(+0.88%)
USD |
NASDAQ |
Dec 10, 16:00
12.60
+0.01
(+0.08%)
Pre-Market: 08:01
RxSight EPS Diluted (Quarterly): -0.2396 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | -0.3495 |
| Xtant Medical Holdings, Inc. | 0.0087 |
| VolitionRX Ltd. | -0.0497 |
| Catheter Precision, Inc. | -1.705 |
| Picard Medical, Inc. | -0.1915 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.816M |
| Revenue (Quarterly) | 30.34M |
| Total Expenses (Quarterly) | 40.16M |
| Enterprise Value | 301.71M |
| Gross Profit Margin (Quarterly) | 79.85% |
| Profit Margin (Quarterly) | -32.35% |
| Earnings Yield | -6.98% |
| Normalized Earnings Yield | -6.975 |